KYTHERA Biopharmaceuticals Inc stock trades on the US exchange.

No recent headlines found in our database. Typically, when a stock ticker symbol changes it is because it merges or is being acquired by another public company. A ticker symbol might also change if the company is late with filing the quarterly filings with the SEC. This is normally shown by adding an E on the end. The E means they are delinquent in filings. If a company were to go bankrupt it would add a Q at the end of the symbol. If a company were to just IPO is might have a D on the end. Please keep in mind too that some indexes and funds might simply just not have a corporate description. It could also mean the stock was de-listed to a lower over the counter exchange.

»»» Detailed Company Profile & Chart

 KYTHERA Biopharmaceuticals Inc current day financials: 2024-04-25 01:14:37am
Symbol Name Purchase price Last Price Change % Change
0.00
KYTHERA Biopharmaceuticals Inc historical financials from '16
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.74
Market Cap (USD)
-
Shares Outstanding (m)
26.301
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Recent KYTH News from Yahoo Finance & Seeking Alpha

Older Archived News KYTHERA Biopharmaceuticals Inc

  • Stocks Turn Lower as Fed Nerves Get the Better of Investors.
  • Crude Oil Boosts Stocks as Domestic Inventories Fall.
  • Kythera Biopharmaceuticals (KYTH) Stock Soaring; Jim Cramer Calls Takeover Deal 'Brilliant'.
  • Stock Futures Are Mixed as Investors Await Fed Announcement.
  • Stocks Climb as Fed Meeting Suggests 2015 Hikes.
  • XBI’s Top Ten Small-Cap Stocks Perform on Par with Large-Caps.
  • What to Expect From Allergan Earnings.
  • KYTHERA® Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss.
  • KYTHERA(R) Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat.
  • KYTHERA(R) Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss.
    • Load More News...